These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19591064)

  • 1. Inquiries about and initiation of buprenorphine treatment in an inner-city clinic.
    Cunningham CO; Giovanniello A; Sacajiu G; Li X; Brisbane M; Sohler NL
    Subst Abus; 2009; 30(3):261-2. PubMed ID: 19591064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
    LaBelle CT; Han SC; Bergeron A; Samet JH
    J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine treatment in an urban community health center: what to expect.
    Cunningham C; Giovanniello A; Sacajiu G; Whitley S; Mund P; Beil R; Sohler N
    Fam Med; 2008; 40(7):500-6. PubMed ID: 18928077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
    James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
    Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
    [No Abstract]   [Full Text] [Related]  

  • 6. Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial.
    Gunderson EW; Wang XQ; Fiellin DA; Bryan B; Levin FR
    Addict Behav; 2010 May; 35(5):537-40. PubMed ID: 20106601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence.
    Clay E; Khemiri A; Zah V; Aballéa S; Ruby J; Asche CV
    J Med Econ; 2014 Sep; 17(9):626-36. PubMed ID: 24841329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
    D'Onofrio G; O'Connor PG; Pantalon MV; Chawarski MC; Busch SH; Owens PH; Bernstein SL; Fiellin DA
    JAMA; 2015 Apr; 313(16):1636-44. PubMed ID: 25919527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series.
    Suzuki J; DeVido J; Kalra I; Mittal L; Shah S; Zinser J; Weiss RD
    Am J Addict; 2015 Jan; 24(1):10-4. PubMed ID: 25823630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design to evaluate a group-based therapy for support persons of adults on buprenorphine/naloxone.
    Osilla KC; Becker K; Ecola L; Hurley B; Manuel JK; Ober A; Paddock SM; Watkins KE
    Addict Sci Clin Pract; 2020 Jul; 15(1):25. PubMed ID: 32653029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating Opioid Dependence with Buprenorphine in the Safety Net: Critical Learning from Clinical Data.
    Rieckmann TR; Gideonse N; Risser A; DeVoe JE; Abraham AJ
    J Behav Health Serv Res; 2017 Jul; 44(3):351-363. PubMed ID: 28488155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
    D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
    J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.
    Mintzer IL; Eisenberg M; Terra M; MacVane C; Himmelstein DU; Woolhandler S
    Ann Fam Med; 2007; 5(2):146-50. PubMed ID: 17389539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.
    Lucas GM; Chaudhry A; Hsu J; Woodson T; Lau B; Olsen Y; Keruly JC; Fiellin DA; Finkelstein R; Barditch-Crovo P; Cook K; Moore RD
    Ann Intern Med; 2010 Jun; 152(11):704-11. PubMed ID: 20513828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public sector low threshold office-based buprenorphine treatment: outcomes at year 7.
    Bhatraju EP; Grossman E; Tofighi B; McNeely J; DiRocco D; Flannery M; Garment A; Goldfeld K; Gourevitch MN; Lee JD
    Addict Sci Clin Pract; 2017 Feb; 12(1):7. PubMed ID: 28245872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of buprenorphine treatment for opioid dependence.
    Murphy SM; Fishman PA; McPherson S; Dyck DG; Roll JR
    J Subst Abuse Treat; 2014 Mar; 46(3):315-9. PubMed ID: 24209382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.
    Roux P; Rojas Castro D; Ndiaye K; Briand Madrid L; Laporte V; Mora M; Maradan G; Morel S; Spire B; Carrieri P
    Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):46. PubMed ID: 29096661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Discontinuation of Buprenorphine Therapy for Opioid Use Disorder Among Privately Insured Adults.
    Agbese E; Leslie DL; Manhapra A; Rosenheck R
    Psychiatr Serv; 2020 Aug; 71(8):779-788. PubMed ID: 32264801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City.
    Truong C; Krawczyk N; Dejman M; Marshall-Shah S; Tormohlen K; Agus D; Bass J
    Addict Behav; 2019 Jun; 93():14-19. PubMed ID: 30682677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.